Egyptian International Pharmaceutical Industries Company (EGX:PHAR)

Egypt flag Egypt · Delayed Price · Currency is EGP
85.89
-0.29 (-0.34%)
At close: Apr 23, 2026
Market Cap14.49B +96.8%
Revenue (ttm)9.44B +24.4%
Net Income1.44B +31.6%
EPS8.89 +20.8%
Shares Out168.76M
PE Ratio9.66
Forward PE9.93
Dividend1.50 (1.75%)
Ex-Dividend DateApr 28, 2026
Volume120,172
Average Volume278,359
Open86.18
Previous Close86.18
Day's Range85.80 - 87.00
52-Week Range43.60 - 88.99
Beta0.57
RSI62.52
Earnings DateMay 14, 2026

About EGX:PHAR

Egyptian International Pharmaceutical Industries Company manufactures and sells pharmaceutical ampoules in Egypt and internationally. The company offers analgesics and antipyretic; analgesics and anti-inflammatory; anti-infective; antihistamine; cardiovascular and metabolic; corticosteroids; gastrointestinal tract; nervous system; ophthalmic; respiratory; topical ointment and cream; vitamins; and miscellaneous products. It also exports its products. Egyptian International Pharmaceutical Industries Company was incorporated in 1980 and is based i... [Read more]

Industry Pharmaceutical Preparations
Founded 1980
Country Egypt
Stock Exchange Egyptian Stock Exchange
Ticker Symbol PHAR
Full Company Profile

Financial Performance

In 2025, EGX:PHAR's revenue was 9.44 billion, an increase of 24.38% compared to the previous year's 7.59 billion. Earnings were 1.44 billion, an increase of 31.57%.

Financial Statements